New Clues To How Humble Painkiller Stifles Cancer Growth
5/26/2011
Cancer Research UK scientists have shed light on how a common class of painkillers - which includes ibuprofen - may interact with a key protein that fuels the growth of many different types of cancer, according to a study published in the journal Chemical Communications today (Thursday)...
NIH Awards $1.36 Million To RPCI Scientists; Unrelated Grant From NCCN Focuses On Care Optimization
5/26/2011
Several Roswell Park Cancer Institute (RPCI) faculty members have received funding from federal agencies or national organizations in support of research projects that further the Institute's mission to understand, prevent and cure cancer...
Oncologists Hold Key To Curbing Cancer Costs
5/26/2011
The cost of cancer care is threatening to bankrupt our healthcare system. New drugs are prolonging life, but at staggering costs. This coupled with aging baby boomers and an increasing population mean the U.S. will spend $173 billion annually on cancer care by the year 2020...
Adaptimmune Announces Opening Of Phase I/II Clinical Trial In Multiple Myeloma
5/26/2011
Adaptimmune announced today that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy...
NIH And Non-Profits Sign Research And Development Agreement
5/26/2011
The National Institutes of Health has announced an agreement with two non-profit organizations to accelerate the development of potential clinical therapies for rare blood cancers...
A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo. The study was sponsored by Janssen...
Complications Arise When Patients Fail To Properly Take Oral Chemo
5/26/2011
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death...
ZYTIGA Phase 3 Study Results Re Metastatic Castration-Resistant Prostate Cancer
5/26/2011
A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA™ (abiraterone acetate) plus prednisone comp...
UMMC Part Of Study Finding Sickle Cell Treatment Safe For Young Children
5/26/2011
A drug now used to treat adults who have sickle cell disease appears to be safe for children aged eight to 19 months, results from a new National Institutes of Health-funded study suggest. The drug, hydroxyurea, reduced pain episodes and improved key blood measurements in the children studied, according to researchers...
Why Do Cancer Cells Easily Give In To The Temptation To Divide?
5/26/2011
Temptations to exceed the speed limit are always plentiful, but only reckless drivers give in to such impulses. Likewise, numerous growth factors always abound in our bodies, but only cancerous cells are quickly "tempted" by these chemicals to divide again and again. Healthy cells, in contrast, divide only after being exposed to growth factors for eight continuous hours...